Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain. - sprookjes - yvandenbroek - TriplyDB

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

http://www.wikidata.org/entity/Q34054649

about

A Gamma-Knife-Enabled Mouse Model of Cerebral Single-Hemisphere Delayed Radiation Necrosis A GSK-3β inhibitor protects against radiation necrosis in mouse brain.Toward distinguishing recurrent tumor from radiation necrosis: DWI and MTC in a Gamma Knife--irradiated mouse glioma model.Perilesional edema in radiation necrosis reflects axonal degeneration Vascular Endothelial Growth Factor Enhanced the Angiogenesis Response of Human Umbilical Cord-Derived Mesenchymal Stromal Cells in a Rat Model of Radiation Myelopathy.Mast Cells Contribute to Radiation-Induced Vascular Hyperpermeability.Specificity of vascular endothelial growth factor treatment for radiation necrosis O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report.Prognosis of local recurrence in giant cell tumour of bone: what can we do?The effect of radiation dose on the onset and progression of radiation-induced brain necrosis in the rat model.Apatinib in refractory radiation-induced brain edema: A case report.Understanding the continuum of radionecrosis and vascular disorders in the brain following gamma knife irradiation: An MRI study.Can anti-vascular endothelial growth factor antibody reverse radiation necrosis? A preclinical investigation.The role of propranolol as a radiosensitizer in gastric cancer treatment.A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.Preclinical MRI: Studies of the irradiated brain Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients

P2860

Q27315120-152A7D9F-094B-4FD1-AB19-955B48DB9397 Q35018692-98B14F79-5E0F-4D99-9B77-5A9657CA3776 Q35018782-EC68D69B-65AE-4C79-8FC6-C43C8D37D4B2 Q35091614-967C2736-CBD6-4063-8C00-83C1801ACD7F Q35733211-F7D60223-2642-41D6-AFEB-B0D974A78E98 Q36600811-A112CC8F-072F-4311-9FE3-3EEE8F84AFEF Q36862591-4B4F5343-6267-4F0B-95F8-8F3DE821B0F3 Q36863384-0ED0769D-6468-4709-9D79-E1EF6AF63E19 Q38635290-29B4443D-7F71-4390-A566-C11F0495A245 Q38779273-4B991CC8-5583-44D8-91A3-5373146CCCC7 Q39167478-96525E6C-32D0-4017-8979-83ACBF381841 Q46671844-0C8CA75A-1F35-4494-9BAD-6116F07CB107 Q47141187-164939EF-5A80-41C8-A35D-EC6F19BB00C2 Q48428404-A0E69C36-242E-471B-9495-E67CD792F915 Q50715361-BD6DB76E-D3C0-491C-B39F-93F92459B410 Q52595303-DEA2CFFF-1545-43D8-979D-73BBE2BA93B7 Q52894585-80C1BBF7-46D9-46C9-B4A6-CB157BB3097C Q57178476-A221F107-BA9A-4A81-9C0A-3112A7A80D24 Q58762991-F279C5DB-B838-4BB8-A3DD-1BD8E88FA819

P2860

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

http://www.wikidata.org/entity/Q34054649

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@ast

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@en

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@nl

type

label

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@ast

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@en

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@nl

prefLabel

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@ast

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@en

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@nl

P1433

Q34054649-43E251A7-4C35-4DBA-8844-89DA76E0CA3A

P1476

Q34054649-1B7A46CC-EE6B-47B9-A37F-29573D1E5953

P2093

Q34054649-02EF6C08-076F-44A0-A892-70005371A7EC

Q34054649-3C292137-ADC1-4D67-9151-EB28C1E0A981

Q34054649-49EB89D5-8F0C-4D11-9586-065CD086007E

Q34054649-628B0C3C-3771-44B9-A47A-0D90D9BC74CE

Q34054649-8520A7DB-AA23-473E-A36A-F02B0000C380

Q34054649-87707009-92B6-4761-B745-0755C6370C4A

Q34054649-A463F352-B2F5-4729-8C98-5323A00D3337

Q34054649-A701B35D-C4B2-497B-AF75-4720874CC2FA

Q34054649-C9A36B2B-3469-4574-8FCE-77621EABD190

P2860

Q34054649-0201E2A3-907B-4D7A-8A77-2604C6D83319

Q34054649-266F2B30-EE2A-4794-96F9-481EF8711064

Q34054649-27A05323-786A-4EB1-BC4E-6F10FB94AEBE

Q34054649-29DD0089-A12B-42F1-83AA-26F4EC8A0F19

Q34054649-2CBAB726-F76B-4422-A1A2-C9308C60B7AB

Q34054649-41BC7070-E6B3-4D6F-B42E-3C742729FCDE

Q34054649-4416E773-A8F5-4406-9345-6DB3BDCC6EA4

Q34054649-4CA39C58-2653-4CD9-A888-1B2E774109D1

Q34054649-598BB4CF-0C77-47A0-B611-C346FFD06716

Q34054649-5CB295A1-C89B-428A-A570-BCE34D4B8AFF

P304

Q34054649-06DF0E50-747E-4455-913E-F8266E5197D8

P31

Q34054649-A74A5E66-F0D8-4873-B7F4-8DBB216E8656

P356

Q34054649-17C59AB0-B013-41E0-A556-484A2389AA1F

P407

Q34054649-CDB54049-719B-4571-8188-9C03E4AA0F56

P433

Q34054649-E03B68AD-0736-4E53-A80E-54FDAF50ED50

P478

Q34054649-8D87F3D3-3FFD-487C-87A8-A9DB3049C283

P50

Q34054649-0690C899-FAE1-4D89-8EC5-20137D947979

Q34054649-80EC41B7-5068-4AEC-832D-4A29EDFAF21F

P577

Q34054649-79A45CF1-4F06-42DA-B349-E53E7070C094

P698

Q34054649-C20FEB5E-8051-4E04-B429-8B4928242EB8

P921

Q34054649-CB75017C-5B36-4F9C-9ED6-6441CCAA7A2A

P932

Q34054649-D52986AD-F1E2-406E-A836-B9C593DFBE4F

P356

1078-0432.CCR-13-1941

P1433

Clinical Cancer Research

P1476

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

@en

P2093

Dennis E Hallahan

http://www.w3.org/2001/XMLSchema#string

Jeremy Cates

http://www.w3.org/2001/XMLSchema#string

Joel R Garbow

http://www.w3.org/2001/XMLSchema#string

John A Engelbach

http://www.w3.org/2001/XMLSchema#string

Joseph J H Ackerman

http://www.w3.org/2001/XMLSchema#string

Keith M Rich

http://www.w3.org/2001/XMLSchema#string

Liya Yuan

http://www.w3.org/2001/XMLSchema#string

Robert E Drzymala

http://www.w3.org/2001/XMLSchema#string

Robert E Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

Random-effects models for longitudinal data

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations.

Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.

Interaction between bevacizumab and murine VEGF-A: a reassessment.

Sensitive blood-retinal barrier breakdown quantitation using Evans blue.

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

P304

2695-2702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-13-1941

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24647570

http://www.w3.org/2001/XMLSchema#string

P921

P932

4135174

http://www.w3.org/2001/XMLSchema#string